Inspyr Therapeutics Reports Financial Results and Business Update For Full Year 2020
- Implements new corporate strategy to focus on precision therapeutics for the treatment of cancer - Strengthens pipeline by acquiring a proprietary portfolio of novel adenosine immuno-modulator compounds...
Inspyr Therapeutics Further Strengthens Global Intellectual Property
WESTLAKE VILLAGE, CA / ACCESSWIRE / February 18, 2021 / Inspyr Therapeutics, Inc. (OTC PINK:NSPX), a pharmaceutical company focused on the research and development of novel targeted precision therapeutics...